2021 – NationX News

Year: 2021

This techie started an agritech startup to help farmers earn a fair price for their produce

India’s agriculture sector has been facing a crisis on many fronts. One of the many

How Katran Foundation is taking the sustainable route by upcycling fabric waste into clothes for underserved children

How Katran Foundation is taking the sustainable route by upcycling fabric waste into clothes for underserved children

Today, while one section of society has the luxury of buying new clothes for every

This fertility tech startup offers affordable, accessible treatment that’s free of gender bias

This fertility tech startup offers affordable, accessible treatment that’s free of gender bias

The World Health Organisation (WHO) states that infertility plagues 30 million couples in India every

Fauci suggests a few weeks’ lockdown in India to break chain of coronavirus transmission

Fauci suggests a few weeks’ lockdown in India to break chain of coronavirus transmission

Top US epidemiologist Anthony Fauci has suggested a lockdown for a few weeks in India

COVID crisis in India very serious, cases yet to peak: US official

COVID crisis in India very serious, cases yet to peak: US official

The COVID-19 crisis in India is indeed very serious, the Biden Administration said on Friday,

M&M to hike stake in Meru to 100 percent

M&M to hike stake in Meru to 100 percent

Mahindra and Mahindra on Friday said it has inked a pact with shareholders of Meru

Complying with the new rule of providing 50 percent doses to state government and open market, Covishield vaccine will now be available at Rs 400 for state governments and Rs 600 for private hospitals. “Owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity. We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems. Post four to five months, the vaccines will be made available in retail and free trade,” SII said in a statement. According to government data, Covishield comprises over 90 percent of the 12.76 crore COVID-19 vaccines administered across the country Apart from this, Covaxin maker Bharat Biotech also said it will produce 30 million doses of its COVID-19 vaccine. The company stated that it has ramped up its production capacity of Covaxin to 700 million doses per annum. "Last month, we produced 15 million doses. This month, we are reaching 20 million doses; next month, we will be making around 30 million doses followed by 70 to 75 million doses. We are ramping up the production and by July-August, we will be able to reach 700 to 800 million doses production capacity per annum," said Krishna Ella, Chairman and MD at Bharat Biotech. On Wednesday, the company revealed that Covaxin has shown the efficacy of 78 percent against mild, moderate, and severe cases of COVID-19 as per Phase III interim analysis results. It also added that results from the final analysis will be available in June. New vaccines in India In order to meet the increasing demand for vaccines, India is also looking at introducing new vaccines to accelerate the fight against COVID-19. Earlier this month, Russian COVID-19 vaccine Sputnik V got permission for restricted emergency use with certain conditions from the Drugs Controller General of India (DCGI) With this approval, Sputnik V has become the third approved vaccine in India against coronavirus. Hyderabad-based pharmaceutical company, Dr. Reddy's Laboratories, which was conducting the Indian trials for Sputnik V will be importing the vaccine for emergency use in India. According to the PTI report, the Sputnik V vaccine is expected to arrive this month or latest by next month. Apart from this, Moderna, and Johnson and Johnson have also been urged to seek emergency use approval in India. In order to meet the vaccine demand, the government is also reportedly considering waiving off 10 percent customs duty levied on imported vaccines to lower the costs of overseas vaccines While vaccine makers and the government is doing their bit to ramp up vaccination efforts to eliminate coronavirus, we can only defeat the pandemic when we follow the advised protocols and take appropriate precautions. Vaccination is a preventive measure and not a cure. With the second wave of infections hitting the country, it is the need of the hour to take measures and cut the curve to eliminate the disease.

Some states to begin jabs for 18-44 years on May 1, vaccination drive to stabilise with time: Centre

Amid many states expressing their inability to start COVID-19 vaccination of those between 18 and

Government to provide Rs 4,500 Cr booster to vaccine manufacturers for ramping up capacity

Apollo, Fortis, Max hospitals to vaccinate 18-44 age group at select centres in country from today

Three big private hospital chains — Apollo, Fortis and Max — on Friday announced the

Insurance scheme for frontline health workers extended for six months

Insurance scheme for frontline health workers extended for six months

The insurance scheme for frontline health workers has been extended for another six months, the

Bharat Biotech says Covaxin shows 78pc efficacy against mild to severe COVID-19

Startup news and updates: daily roundup

COVID crisis in India very serious, cases yet to peak: US official The COVID-19 crisis